exactly. it would be unfortunate if they were NOT warranted. but as you say, they ARE warranted. glad you're finally seeing the light!
jonnie voluntarily reduced his salary to $1 per month UNTIL THE COMPANY BECOMES PROFITABLE...his agreement. i don't mind paying him two years' worth of severance at the salary rate for his final couple of years, or a total of $24.
if an employee of mine suddenly decides to resign, that's fine, but i'm not going to continue paying him for three months while not working. it seems chapman botched up the fda scenario recently, unbeknownst to others, and who knows what else, and was then probably asked to leave or else be fired. so he agrees to quietly leave with three months severance. reminds me of the tabloids whenever a celebrity couple files for divorce, where they mutually agreed it was time to separate, and they remain great friends. bull. they mutually agree because they pretty much must. one person is generally angry, and they probably are not on wonderful terms.
just my thoughts in this cotton candy media world.
perusing once again mullan's linkedin profile, I notice some new faces on his top ten "People Also Viewed" (viewers of mullan have also viewed these profiles). could be completely immaterial. simply an observation.
Stephen simes ~ CEO at Restorgenex Corp - "Public company CEO and Board Director with a proven track record of drug approvals, financings, and business development transactions. Extensive experience in formulating and implementing corporate strategies, establishing growth metrics, driving performance, and meeting growth objectives through both organic expansion and strategic acquisitions and partnerships."
Robert hutchens ~ CEO at StemBioSys - "Over 25 years of experience in a broad range of industries and management topics. Significant management consulting experience in Life Sciences that I have applied in both traditional private sector environments (Pharmaceutical, Medical Device Companies) as well as in a variety of U.S. Federal Government and International NGO organizations.
Official Title: 3-Part Study With 2 6-Period Single Dose Parts (Pt 1, Pt 2 Optional) Followed by a 1-Period Multiple Dose Part (Pt 3) to Evaluate Prototype Modified Release MATRIX and Multi Particulate Formulations of Anatabine Citrate to Determine PK
Estimated Enrollment: 37
Study Start Date: January 2015
Estimated Study Completion Date: September 2015
Estimated Primary Completion Date: September 2015
Trinity: Neo... nobody has ever done this before.
Neo: I know. That's why it's going to work.
I just thought it was a funny headline ~ "Update: Rock Creek Pharmaceuticals IR Says There is No News"
THAT'S the news...NO news! so a writer or someone calls rock creek because share price bumped up a bit. "Is there news?" what are they supposed to say? YES, there is (and hence, insider trading)! Of course there's "no news", at least that they can share, until they decide to share it. you don't call apple or yahoo and ask if there's news. THEY tell you when there's news and no sooner. there is never news until a company is ready to offer it.
Nilvad reaches recruitment target of 510 people in phase III trial.
Please do not ask how this may possibly relate to rcpi or anatabine citrate...unless you're new. :)
I'm not sure if this is new or not, but it's new to me. On the rock website, if you click "LEADERSHIP", there are three sub-headings. I've seen "MANAGEMENT PROFILES" and "BOARD OF DIRECTORS", but now notice a third entitled "SCIENTIFIC ADVISORY", which states "COMING SOON" when you click it.
Anyone seen this before?
For sale: A 14,700-square-foot mansion and a total of 61 acres of property in middle of the prestigious Hermitage Golf Course in Goochland County.
Price: $4.9 million
Seller: jonnie r. williams
"Williams is said to have properties in the Bradenton and Sarasota, Florida, areas."
to be fair, drum, perhaps we should also mention from the article:
"But the so-called “amyloid hypothesis” is controversial, and other drugs targeted at amyloid plaques have failed in late-stage studies."
"The most serious adverse event associated with aducanumab was the presence of the fluids surrounding patients’ blood vessels in imaging scans, also known as amyloid-related imaging abnormalities, or ARIA"
and a comment below the article:
"The side effects list should have also included the following: Involuntary body spasms, prickly skin sensations, pulsation in the cranium and spatial problems. Each of these side effects are most prevalent from 4:00PM -10:00PM and may be fatigue related. They can occur simultaneously! A reduction in the amount of light may also bring them on. And an increase in stress can trigger them at any time. These side effects are terrible for the patient and for anyone witnessing them!"
if and when biogen's potential drug is pulled as others have been, rcpi's anatabine citrate should be nice and ripe as pharmas look elsewhere!
with no hope, drum and friends would waste no time penning their doomsday thoughts. they would simply ride the wave down. but they know what we know. there is undeniable hope. they will deny it, but the prospect of positive results is the only reason they persist.
institutions are indeed watching and waiting.
rcpi holds a potential remedy for a huge need Hopkins is now discovering. think, drum...think.
"Drug development company Rock Creek Pharmaceuticals has announced a new clinical trial application with the Medicines Healthcare Products Regulatory Agency (MHRA) has been approved. The company is set to proceed with a Phase I study of Anatabine Citrate, a chemical that is found naturally in aubergine, potatoes, green tomatoes and other members of the Solanaceae family of plants, as well as in tobacco and tobacco smoke. The chemical is known for its anti-inflammatory properties unique from other anti-inflammatory drugs on the market, and may benefit patients with multiple sclerosis (MS)."
from DisabilityToday in the UK:
“Since MS is a chronic inflammatory disorder, having enough nutrients with anti-inflammatory properties may help prevent the disease or reduce the risk of attacks for those who already have MS,” said study author Sandra D. Cassard, ScD, with John Hopkins University in Baltimore, MD in a recent news release. “Antioxidants are also critical to good health and help reduce the effects of other types of damage that can occur on a cellular level and contribute to neurologic diseases like MS. Whether the nutritional differences that we identified in the study are a cause of MS or a result of having it is not yet clear.”
Compared to healthy people, women with multiple sclerosis (MS) may have inferior levels of certain antioxidants and nutrients with anti-inflammatory properties, including vitamin E and folate, according to a new study funded by the National Institute of Neurological Disorders and Stroke (NINDS).
A research team led by Dr. Sandra D. Cassard of Johns Hopkins University in Baltimore, MD will present their findings during the American Academy of Neurology’s 67th Annual Meeting in Washington, DC in April..."